Vaccine News and Research

Latest Vaccine News and Research

Soligenix first-quarter revenues decrease to $336,000

Soligenix first-quarter revenues decrease to $336,000

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Celldex Therapeutics commences screening in CDX-1307 Phase 2 study for bladder cancer

Scientists find clues to how our brains work

Scientists find clues to how our brains work

Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

Cell Therapeutics' Special Meeting of Shareholders adjourned to June 4, 2010

Miami-area resident charged in $23M HIV infusion Medicare fraud scheme

Miami-area resident charged in $23M HIV infusion Medicare fraud scheme

Biovest International announces filing of proposed Plan of Reorganization

Biovest International announces filing of proposed Plan of Reorganization

HSPH researchers succeed in locking malaria parasites within infected blood cells

HSPH researchers succeed in locking malaria parasites within infected blood cells

Science special issue reports on Malaria

Science special issue reports on Malaria

Hiru Corporation completes Quarterly Report

Hiru Corporation completes Quarterly Report

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Amgen submits BLA for denosumab subcutaneous RANK Ligand inhibitor

Recent releases in Global Health

Recent releases in Global Health

U.S. healthcare practitioners can resume use of Rotarix, says FDA

U.S. healthcare practitioners can resume use of Rotarix, says FDA

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

Caliper Life Sciences' CDAS unit awarded new funding commitment for EPA ToxCast screening program

Caliper Life Sciences' CDAS unit awarded new funding commitment for EPA ToxCast screening program

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

Each melanoma cell capable of cancer stem cell behavior: Study

Each melanoma cell capable of cancer stem cell behavior: Study

Inhibitex reports net loss of $4.8M for first-quarter 2010

Inhibitex reports net loss of $4.8M for first-quarter 2010

Emergent BioSolutions named Biotechnology Firm of the Year at TCM's Annual Tech Awards

Emergent BioSolutions named Biotechnology Firm of the Year at TCM's Annual Tech Awards

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.